Type I Interferon Signaling Induces Melanoma Cell-Intrinsic PD-1 and Its Inhibition Antagonizes Immune Checkpoint Blockade

Researchers demonstrated induction of PD-1 in melanoma cells via type I interferon receptor (IFNAR) signaling and reversal of immune checkpoint blockade efficacy through IFNAR pathway inhibition.